John Pang

Dr. John Pang

Department of Otolaryngology/Head and Neck Surgery, LSU Health, Shreveport, LA, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RORyan K. Orosco
Ryan K. Orosco
VTViridiana J. Tapia
Viridiana J. Tapia
JCJoseph A. Califano
Joseph A. Califano
BCBryan Clary
Bryan Clary
ECEzra E. W. Cohen
Ezra E. W. Cohen
QNQuyen T. Nguyen
Quyen T. Nguyen
A positive surgical margin (PSM) following cancer resection oftentimes necessitates adjuvant treatments and carries significant financial and prognostic implications. We sought to compare PSM rates for the ten most common solid cancers in the United States, and to assess trends over time. Over 10 million patients were identified in the National Cancer Data Base from 1998–2012, and 6.5 million had surgical margin data. PSM rates were compared between two time periods, 1998–2002 and 2008–2012. PSM was positively correlated with tumor category and grade. Ovarian and prostate cancers had the highest PSM prevalence in women and men, respectively. The highest PSM rates for cancers affecting both genders were seen for oral cavity tumors. PSM rates for breast cancer and lung and bronchus cancer in both men and women declined over the study period. PSM increases were seen for bladder, colon and rectum, and kidney and renal pelvis cancers. This large-scale analysis appraises the magnitude of PSM in the United States in order to focus future efforts on improving oncologic surgical care with the goal of optimizing value and improving patient outcomes.

11 August 2016 in Scientific Reports
Verified
Journal Article
Open access
DCDamon S. Cooney
Damon S. Cooney
EWEric G. Wimmers
Eric G. Wimmers
ZIZuhaib Ibrahim
Zuhaib Ibrahim
JGJohanna Grahammer
Johanna Grahammer
JCJoani M. Christensen
Joani M. Christensen
GBGerald Brandacher
Gerald Brandacher
This study investigates the efficacy of local and intravenous mesenchymal stem cell (MSC) administration to augment neuroregeneration in both a sciatic nerve cut-and-repair and rat hindlimb transplant model. Bone marrow-derived MSCs were harvested and purified from Brown-Norway (BN) rats. Sciatic nerve transections and repairs were performed in three groups of Lewis (LEW) rats: negative controls (n = 4), local MSCs (epineural) injection (n = 4), and systemic MSCs (intravenous) injection (n = 4). Syngeneic (LEW-LEW) (n = 4) and allogeneic (BN-LEW) (n = 4) hindlimb transplants were performed and assessed for neuroregeneration after local or systemic MSC treatment. Rats undergoing sciatic nerve cut-and-repair and treated with either local or systemic injection of MSCs had significant improvement in the speed of recovery of compound muscle action potential amplitudes and axon counts when compared with negative controls. Similarly, rats undergoing allogeneic hindlimb transplants treated with local injection of MSCs exhibited significantly increased axon counts. Similarly, systemic MSC treatment resulted in improved nerve regeneration following allogeneic hindlimb transplants. Systemic administration had a more pronounced effect on electromotor recovery while local injection was more effective at increasing fiber counts, suggesting different targets of action. Local and systemic MSC injections significantly improve the pace and degree of nerve regeneration after nerve injury and hindlimb transplantation.

23 February 2018 in WIREs Mechanisms of Disease
Verified
Journal Article
Closed access
PDF file
KTKathryn R. Tringale
Kathryn R. Tringale
JPJohn Pang
John Pang
QNQuyen T. Nguyen
Quyen T. Nguyen

1 December 2017 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
JPJohn Pang
John Pang
KTKathryn R. Tringale
Kathryn R. Tringale
VTViridiana J. Tapia
Viridiana J. Tapia
WMWilliam J. Moss
William J. Moss
MMMegan E. May
Megan E. May
JCJoseph A. Califano
Joseph A. Califano
Chronic pain is a major concern for patients with head and neck cancer (HNC), affecting up to 60% of survivors.1,2 Despite the need to effectively manage chronic pain, a recent meta-analysis3 of pain management in patients with cancer concluded that nearly half are not optimally treated. In 2013, the National Comprehensive Cancer Network (NCCN) released its first set of clinical practice guidelines in an effort to improve survivorship of patients with cancer. Pain management was 1 of 8 domains receiving specific attention in these guidelines.4

27 April 2015 in Head & Neck
Verified
Journal Article
Closed access
PDF file
JPJohn Pang
John Pang
WMWojciech K. Mydlarz
Wojciech K. Mydlarz
ZGZhen Gooi
Zhen Gooi
KWKevin M. Waters
Kevin M. Waters
JBJustin Bishop
Justin Bishop
CFCarole Fakhry
Carole Fakhry

1 June 2015 in Journal of Neurosurgery: Spine
Verified
Journal Article
Closed access
JKJennifer E. Kim
Jennifer E. Kim
JPJohn Pang
John Pang
JCJoani M. Christensen
Joani M. Christensen
DCDevin Coon
Devin Coon
PZPatricia L. Zadnik
Patricia L. Zadnik
JSJustin M. Sacks
Justin M. Sacks
OBJECT: Total en bloc sacrectomy is a dramatic procedure that results in extensive sacral defects. The authors present a series of patients who underwent flap reconstruction after total sacrectomy, report clinical outcomes, and provide a treatment algorithm to guide surgical care of this unique patient population. METHODS: After institutional review board approval, data were collected for all patients who underwent total sacrectomy between 2002 and 2012 at The Johns Hopkins Hospital. Variables included demographic data, medical history, tumor characteristics, surgical details, postoperative complications, and clinical outcomes. All subtotal sacrectomies were excluded. RESULTS: Between 2002 and 2012, 9 patients underwent total sacrectomy with flap reconstruction. Diagnoses included chordoma (n = 5), osteoblastoma (n = 1), sarcoma (n = 2), and metastatic colon cancer (n = 1). Six patients received gluteus maximus (GM) flaps with a prosthetic rectal sling following a single-stage, posterior sacrectomy. Four required additional paraspinous muscle (PSM) or pedicled latissimus dorsi (LD) fasciocutaneous flaps. Three patients underwent multistage sacrectomy with an anterior-posterior approach, 2 of whom received pedicled vertical rectus abdominis myocutaneous (VRAM) flaps, and 1 of whom received local GM, LD, and PSM flaps. Flap complications included dehiscence (n = 4) and infection (n = 1). During the 1st year of follow-up, 2 of 9 patients (22%) were able to ambulate with an assistive device by the 1st postoperative month, and 6 of 9 (67%) were ambulatory with a walker by the 3rd postoperative month. By postoperative Month 12, 5 of 9 patients (56%)—or 5 of 5 patients not lost to follow-up (100%)—were able to able to ambulate independently. CONCLUSIONS: The authors' experience suggests that the GM and pedicled VRAM flaps are reliable options for softtissue reconstruction of total sacrectomy defects. For posterior-only operations, GM flaps with or without a prosthetic rectal sling are generally used. For multistage operations including a laparotomy, the authors consider the pedicled VRAM flap to be the gold standard for simultaneous reconstruction of the pelvic diaphragm and obliteration of dead space.